InvestorsHub Logo

llh222

07/04/20 11:27 PM

#90880 RE: DonDonDonDon #90875

WOW What a summary. I never could take god notes in school.

Thank You

LLH

DJknows

07/04/20 11:40 PM

#90887 RE: DonDonDonDon #90875

To whoever posted that ... excellent and comprehensive!

Awesome interview, covering a lot of ground!

Just to add about our leading man, Dr. Nader Pourhassan... a lot of class and quite the gentleman as well as learned, knowledgeable and apparently apprised of every detail of CytoDyn and Leronlimab... seemingly honest, candid, factual and relentless yet with heart; just the kind of CEO didnt' think I'd ever find in this OTC gutter (hopefully not for long)...

I love finding out what's going on with CytoDyn, its people and its affiliated partners... not to mention the main attraction Leronlimab and it's great potential for all the indications and especially now for Covid-19.

It was on the June 11th CC that Dr. Pourhassan first brought up the Professor at Montefiore Medical Center (Albert Einstein College of Medicine) who wanted to do a trial on 400 Alzheimers patients with Leronlimab. Now we know the name of that Professor is Dr. Parviz Lalezari who happens to be Dr. Jacob Lalezari's father and that Pourhassan has known for a long time. Love the connections and networking in the medical industry!

Another important factor is our "HERO DOCTOR" HARISH SEETHAMRAJU... CytoDyn/Leronlimab may not be here without him.

Glad to be a small part of CytoDyn which seems destined to go down in history as the golden gate of medical breakthroughs for humankind!






ombowstring

07/04/20 11:56 PM

#90893 RE: DonDonDonDon #90875

Excellent summary - maybe the definitive summary. Two points that I'd like to emphasize is that Big Media wants to report the story if leronlimab is approved on the basis of the Phase 2 results and the Phase 2b/3 interim analysis if it is allowed by the FDA. The second is that NP was decidedly unsure if FDA approval will come based on the forthcoming data. But if the results are stellar & maybe if we have a Big Pharma partner, how can approval be denied?

Amatuer17

07/05/20 7:18 AM

#90937 RE: DonDonDonDon #90875

Good summary and well covered.

He briefly mentioned BTD - so it is not rejected - seems to be with FDA

daemon57

07/05/20 8:12 AM

#90944 RE: DonDonDonDon #90875

"- Interviewer offers to connect CYDY with these countries"

This seems a very big deal, Dr Been said that he will connect well positioned in other countries (assuming India, Pakistan, etc) with NP very quickly to get trials started over there.
If not the US getting approval, or Mexico, there are other countries.

LOL83001

07/05/20 10:52 AM

#90982 RE: DonDonDonDon #90875

DonDon: FYI "GBHT (?) - going on" is

Graft Versus Host Disease - GVHD. I invested 5 years ago in CYDY for the HIV indication. I invested further when I learned there was a potential to treat GVHD as a dear friend needed a bone marrow transplant and GVHD is a known complication. He had the transplant, and was impacted by GVHD. He passed last October before we could get him into a Leronlimab trial.

Learn more: https://www.lls.org/treatment/types-of-treatment/stem-cell-transplantation/graft-versus-host-disease